MedAdvisor Limited (ASX:MDR)
0.0700
-0.0050 (-6.67%)
Aug 1, 2025, 4:10 PM AEST
MedAdvisor Market Cap
MedAdvisor has a market cap or net worth of 43.77 million as of August 1, 2025. Its market cap has decreased by -83.44% in one year.
Market Cap
43.77M
Enterprise Value
50.27M
Revenue
103.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since December 1, 2015, MedAdvisor's market cap has increased from 35.72M to 43.77M, an increase of 22.52%. That is a compound annual growth rate of 2.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 43.77M | -64.75% |
Dec 31, 2024 | 124.18M | 5.60% |
Dec 29, 2023 | 117.59M | -16.84% |
Dec 30, 2022 | 141.40M | -5.27% |
Dec 31, 2021 | 149.26M | 16.96% |
Dec 31, 2020 | 127.61M | 44.13% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Dec 1, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 131.27B |
Pro Medicus | 33.76B |
Cochlear | 20.72B |
Sonic Healthcare | 13.93B |
Ramsay Health Care | 8.94B |
Telix Pharmaceuticals | 6.95B |
Ansell | 4.40B |
Mesoblast | 3.19B |